What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global Cancer Tumor Profiling Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publish Date: Mar, 2020
Report ID: 413588
Category: Pharmaceuticals and Healthcare
Pages: 127

$3480

Market Overview

The global Cancer Tumor Profiling market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 54970 million by 2025, from USD 37570 million in 2019.

The Cancer Tumor Profiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Cancer Tumor Profiling market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Cancer Tumor Profiling market has been segmented into:

Next-generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Immunohistochemistry (IHC)

In Situ Hybridization (ISH)

Microarray

Others

By Application, Cancer Tumor Profiling has been segmented into:

Personalized Medicine

Diagnostics

Biomarker Discovery

Prognostics

Research Applications

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Tumor Profiling market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Tumor Profiling markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Tumor Profiling market.

The report offers in-depth assessment of the growth and other aspects of the Cancer Tumor Profiling market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Cancer Tumor Profiling Market Share Analysis

Cancer Tumor Profiling competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Tumor Profiling sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Tumor Profiling sales, revenue and market share for each player covered in this report.

The major players covered in Cancer Tumor Profiling are:

Qiagen N.V.

Hologic Gen-Probe

Illumina Inc.

Roche Molecular Systems Inc.

Genomic Health Inc.

Abott Molecular

Siemens Healthineers

HTG Molecular Diagnostic

NeoGenomics Laboratories

BD Biosciences

V., Strand

Agendia

Claris Life Sciences

ApoCell

Foundation Medicine, Inc

Personal Genome Diagnostics, Inc.

GenScript

Contextual Genomics

Perthera, Inc.

Request Sample Request for Customization

Table of Contents

1 Cancer Tumor Profiling Market Overview

1.1 Product Overview and Scope of Cancer Tumor Profiling

1.2 Classification of Cancer Tumor Profiling by Type

1.2.1 Global Cancer Tumor Profiling Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Cancer Tumor Profiling Revenue Market Share by Type in 2019

1.2.3 Next-generation Sequencing (NGS)

1.2.4 Polymerase Chain Reaction (PCR)

1.2.5 Immunohistochemistry (IHC)

1.2.6 In Situ Hybridization (ISH)

1.2.7 Microarray

1.2.8 Others

1.3 Global Cancer Tumor Profiling Market by Application

1.3.1 Overview: Global Cancer Tumor Profiling Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Personalized Medicine

1.3.3 Diagnostics

1.3.4 Biomarker Discovery

1.3.5 Prognostics

1.3.6 Research Applications

1.4 Global Cancer Tumor Profiling Market by Regions

1.4.1 Global Cancer Tumor Profiling Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Cancer Tumor Profiling (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Cancer Tumor Profiling Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Tumor Profiling Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Tumor Profiling Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Cancer Tumor Profiling Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Tumor Profiling Status and Prospect (2015-2025)

2 Company Profiles

2.1 Qiagen N.V.

2.1.1 Qiagen N.V. Details

2.1.2 Qiagen N.V. Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Qiagen N.V. SWOT Analysis

2.1.4 Qiagen N.V. Product and Services

2.1.5 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.2 Hologic Gen-Probe

2.2.1 Hologic Gen-Probe Details

2.2.2 Hologic Gen-Probe Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Hologic Gen-Probe SWOT Analysis

2.2.4 Hologic Gen-Probe Product and Services

2.2.5 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.3 Illumina Inc.

2.3.1 Illumina Inc. Details

2.3.2 Illumina Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Illumina Inc. SWOT Analysis

2.3.4 Illumina Inc. Product and Services

2.3.5 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.4 Roche Molecular Systems Inc.

2.4.1 Roche Molecular Systems Inc. Details

2.4.2 Roche Molecular Systems Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Roche Molecular Systems Inc. SWOT Analysis

2.4.4 Roche Molecular Systems Inc. Product and Services

2.4.5 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.5 Genomic Health Inc.

2.5.1 Genomic Health Inc. Details

2.5.2 Genomic Health Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Genomic Health Inc. SWOT Analysis

2.5.4 Genomic Health Inc. Product and Services

2.5.5 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.6 Abott Molecular

2.6.1 Abott Molecular Details

2.6.2 Abott Molecular Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Abott Molecular SWOT Analysis

2.6.4 Abott Molecular Product and Services

2.6.5 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.7 Siemens Healthineers

2.7.1 Siemens Healthineers Details

2.7.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Siemens Healthineers SWOT Analysis

2.7.4 Siemens Healthineers Product and Services

2.7.5 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.8 HTG Molecular Diagnostic

2.8.1 HTG Molecular Diagnostic Details

2.8.2 HTG Molecular Diagnostic Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 HTG Molecular Diagnostic SWOT Analysis

2.8.4 HTG Molecular Diagnostic Product and Services

2.8.5 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.9 NeoGenomics Laboratories

2.9.1 NeoGenomics Laboratories Details

2.9.2 NeoGenomics Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 NeoGenomics Laboratories SWOT Analysis

2.9.4 NeoGenomics Laboratories Product and Services

2.9.5 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.10 BD Biosciences

2.10.1 BD Biosciences Details

2.10.2 BD Biosciences Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 BD Biosciences SWOT Analysis

2.10.4 BD Biosciences Product and Services

2.10.5 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.11 V., Strand

2.11.1 V., Strand Details

2.11.2 V., Strand Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 V., Strand SWOT Analysis

2.11.4 V., Strand Product and Services

2.11.5 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.12 Agendia

2.12.1 Agendia Details

2.12.2 Agendia Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Agendia SWOT Analysis

2.12.4 Agendia Product and Services

2.12.5 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.13 Claris Life Sciences

2.13.1 Claris Life Sciences Details

2.13.2 Claris Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Claris Life Sciences SWOT Analysis

2.13.4 Claris Life Sciences Product and Services

2.13.5 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.14 ApoCell

2.14.1 ApoCell Details

2.14.2 ApoCell Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 ApoCell SWOT Analysis

2.14.4 ApoCell Product and Services

2.14.5 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.15 Foundation Medicine, Inc

2.15.1 Foundation Medicine, Inc Details

2.15.2 Foundation Medicine, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Foundation Medicine, Inc SWOT Analysis

2.15.4 Foundation Medicine, Inc Product and Services

2.15.5 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.16 Personal Genome Diagnostics, Inc.

2.16.1 Personal Genome Diagnostics, Inc. Details

2.16.2 Personal Genome Diagnostics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 Personal Genome Diagnostics, Inc. SWOT Analysis

2.16.4 Personal Genome Diagnostics, Inc. Product and Services

2.16.5 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.17 GenScript

2.17.1 GenScript Details

2.17.2 GenScript Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 GenScript SWOT Analysis

2.17.4 GenScript Product and Services

2.17.5 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.18 Contextual Genomics

2.18.1 Contextual Genomics Details

2.18.2 Contextual Genomics Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 Contextual Genomics SWOT Analysis

2.18.4 Contextual Genomics Product and Services

2.18.3 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

2.19 Perthera, Inc.

2.19.1 Perthera, Inc. Details

2.19.2 Perthera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.19.3 Perthera, Inc. SWOT Analysis

2.19.4 Perthera, Inc. Product and Services

2.19.5 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Cancer Tumor Profiling Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Cancer Tumor Profiling Players Market Share

3.2.2 Top 10 Cancer Tumor Profiling Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Cancer Tumor Profiling Revenue and Market Share by Regions

4.2 North America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

4.3 Europe Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

4.5 South America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

5 North America Cancer Tumor Profiling Revenue by Countries

5.1 North America Cancer Tumor Profiling Revenue by Countries (2015-2020)

5.2 USA Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

5.3 Canada Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

5.4 Mexico Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

6 Europe Cancer Tumor Profiling Revenue by Countries

6.1 Europe Cancer Tumor Profiling Revenue by Countries (2015-2020)

6.2 Germany Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

6.3 UK Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

6.4 France Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

6.5 Russia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

6.6 Italy Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Cancer Tumor Profiling Revenue by Countries

7.1 Asia-Pacific Cancer Tumor Profiling Revenue by Countries (2015-2020)

7.2 China Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

7.3 Japan Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

7.4 Korea Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

7.5 India Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

8 South America Cancer Tumor Profiling Revenue by Countries

8.1 South America Cancer Tumor Profiling Revenue by Countries (2015-2020)

8.2 Brazil Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

8.3 Argentina Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Cancer Tumor Profiling by Countries

9.1 Middle East & Africa Cancer Tumor Profiling Revenue by Countries (2015-2020)

9.2 Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

9.3 UAE Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

9.4 Egypt Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

9.5 South Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Cancer Tumor Profiling Revenue and Market Share by Type (2015-2020)

10.2 Global Cancer Tumor Profiling Market Forecast by Type (2019-2024)

10.3 Next-generation Sequencing (NGS) Revenue Growth Rate (2015-2025)

10.4 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2025)

10.5 Immunohistochemistry (IHC) Revenue Growth Rate (2015-2025)

10.6 In Situ Hybridization (ISH) Revenue Growth Rate (2015-2025)

10.7 Microarray Revenue Growth Rate (2015-2025)

10.8 Others Revenue Growth Rate (2015-2025)

11 Global Cancer Tumor Profiling Market Segment by Application

11.1 Global Cancer Tumor Profiling Revenue Market Share by Application (2015-2020)

11.2 Cancer Tumor Profiling Market Forecast by Application (2019-2024)

11.3 Personalized Medicine Revenue Growth (2015-2020)

11.4 Diagnostics Revenue Growth (2015-2020)

11.5 Biomarker Discovery Revenue Growth (2015-2020)

11.6 Prognostics Revenue Growth (2015-2020)

11.7 Research Applications Revenue Growth (2015-2020)

12 Global Cancer Tumor Profiling Market Size Forecast (2021-2025)

12.1 Global Cancer Tumor Profiling Market Size Forecast (2021-2025)

12.2 Global Cancer Tumor Profiling Market Forecast by Regions (2021-2025)

12.3 North America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

12.4 Europe Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

12.6 South America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Cancer Tumor Profiling Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Cancer Tumor Profiling by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Cancer Tumor Profiling Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Cancer Tumor Profiling Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Qiagen N.V. Corporate Information, Location and Competitors

Table 6. Qiagen N.V. Cancer Tumor Profiling Major Business

Table 7. Qiagen N.V. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 8. Qiagen N.V. SWOT Analysis

Table 9. Qiagen N.V. Cancer Tumor Profiling Product and Solutions

Table 10. Qiagen N.V. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 11. Hologic Gen-Probe Corporate Information, Location and Competitors

Table 12. Hologic Gen-Probe Cancer Tumor Profiling Major Business

Table 13. Hologic Gen-Probe Cancer Tumor Profiling Total Revenue (USD Million) (2018-2019)

Table 14. Hologic Gen-Probe SWOT Analysis

Table 15. Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions

Table 16. Hologic Gen-Probe Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 17. Illumina Inc. Corporate Information, Location and Competitors

Table 18. Illumina Inc. Cancer Tumor Profiling Major Business

Table 19. Illumina Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 20. Illumina Inc. SWOT Analysis

Table 21. Illumina Inc. Cancer Tumor Profiling Product and Solutions

Table 22. Illumina Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 23. Roche Molecular Systems Inc. Corporate Information, Location and Competitors

Table 24. Roche Molecular Systems Inc. Cancer Tumor Profiling Major Business

Table 25. Roche Molecular Systems Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 26. Roche Molecular Systems Inc. SWOT Analysis

Table 27. Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions

Table 28. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 29. Genomic Health Inc. Corporate Information, Location and Competitors

Table 30. Genomic Health Inc. Cancer Tumor Profiling Major Business

Table 31. Genomic Health Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 32. Genomic Health Inc. SWOT Analysis

Table 33. Genomic Health Inc. Cancer Tumor Profiling Product and Solutions

Table 34. Genomic Health Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 35. Abott Molecular Corporate Information, Location and Competitors

Table 36. Abott Molecular Cancer Tumor Profiling Major Business

Table 37. Abott Molecular Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 38. Abott Molecular SWOT Analysis

Table 39. Abott Molecular Cancer Tumor Profiling Product and Solutions

Table 40. Abott Molecular Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 41. Siemens Healthineers Corporate Information, Location and Competitors

Table 42. Siemens Healthineers Cancer Tumor Profiling Major Business

Table 43. Siemens Healthineers Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 44. Siemens Healthineers SWOT Analysis

Table 45. Siemens Healthineers Cancer Tumor Profiling Product and Solutions

Table 46. Siemens Healthineers Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 47. HTG Molecular Diagnostic Corporate Information, Location and Competitors

Table 48. HTG Molecular Diagnostic Cancer Tumor Profiling Major Business

Table 49. HTG Molecular Diagnostic Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 50. HTG Molecular Diagnostic SWOT Analysis

Table 51. HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions

Table 52. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 53. NeoGenomics Laboratories Corporate Information, Location and Competitors

Table 54. NeoGenomics Laboratories Cancer Tumor Profiling Major Business

Table 55. NeoGenomics Laboratories Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 56. NeoGenomics Laboratories SWOT Analysis

Table 57. NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions

Table 58. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 59. BD Biosciences Corporate Information, Location and Competitors

Table 60. BD Biosciences Cancer Tumor Profiling Major Business

Table 61. BD Biosciences Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 62. BD Biosciences SWOT Analysis

Table 63. BD Biosciences Cancer Tumor Profiling Product and Solutions

Table 64. BD Biosciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 65. V., Strand Corporate Information, Location and Competitors

Table 66. V., Strand Cancer Tumor Profiling Major Business

Table 67. V., Strand Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 68. V., Strand SWOT Analysis

Table 69. V., Strand Cancer Tumor Profiling Product and Solutions

Table 70. V., Strand Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 71. Agendia Corporate Information, Location and Competitors

Table 72. Agendia Cancer Tumor Profiling Major Business

Table 73. Agendia Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 74. Agendia SWOT Analysis

Table 75. Agendia Cancer Tumor Profiling Product and Solutions

Table 76. Agendia Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 77. Claris Life Sciences Corporate Information, Location and Competitors

Table 78. Claris Life Sciences Cancer Tumor Profiling Major Business

Table 79. Claris Life Sciences Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 80. Claris Life Sciences SWOT Analysis

Table 81. Claris Life Sciences Cancer Tumor Profiling Product and Solutions

Table 82. Claris Life Sciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 83. ApoCell Corporate Information, Location and Competitors

Table 84. ApoCell Cancer Tumor Profiling Major Business

Table 85. ApoCell Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 86. ApoCell SWOT Analysis

Table 87. ApoCell Cancer Tumor Profiling Product and Solutions

Table 88. ApoCell Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 89. Foundation Medicine, Inc Corporate Information, Location and Competitors

Table 90. Foundation Medicine, Inc Cancer Tumor Profiling Major Business

Table 91. Foundation Medicine, Inc Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 92. Foundation Medicine, Inc SWOT Analysis

Table 93. Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions

Table 94. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 95. Personal Genome Diagnostics, Inc. Corporate Information, Location and Competitors

Table 96. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Major Business

Table 97. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 98. Personal Genome Diagnostics, Inc. SWOT Analysis

Table 99. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions

Table 100. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 101. GenScript Corporate Information, Location and Competitors

Table 102. GenScript Cancer Tumor Profiling Major Business

Table 103. GenScript Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 104. GenScript SWOT Analysis

Table 105. GenScript Cancer Tumor Profiling Product and Solutions

Table 106. GenScript Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 107. Contextual Genomics Cancer Tumor Profiling Type and Application

Table 108. Contextual Genomics Cancer Tumor Profiling Major Business

Table 109. Contextual Genomics Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 110. Contextual Genomics SWOT Analysis

Table 111. Contextual Genomics Cancer Tumor Profiling Product and Solutions

Table 112. Contextual Genomics Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 113. Perthera, Inc. Corporate Information, Location and Competitors

Table 114. Perthera, Inc. Cancer Tumor Profiling Major Business

Table 115. Perthera, Inc. Cancer Tumor Profiling Total Revenue (USD Million) (2017-2018)

Table 116. Perthera, Inc. SWOT Analysis

Table 117. Perthera, Inc. Cancer Tumor Profiling Product and Solutions

Table 118. Perthera, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 119. Global Cancer Tumor Profiling Revenue (Million USD) by Players (2015-2020)

Table 120. Global Cancer Tumor Profiling Revenue Share by Players (2015-2020)

Table 121. Global Cancer Tumor Profiling Revenue (Million USD) by Regions (2015-2020)

Table 122. Global Cancer Tumor Profiling Revenue Market Share by Regions (2015-2020)

Table 123. North America Cancer Tumor Profiling Revenue by Countries (2015-2020)

Table 124. North America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Table 125. Europe Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)

Table 126. Asia-Pacific Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)

Table 127. South America Cancer Tumor Profiling Revenue by Countries (2015-2020)

Table 128. South America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Table 129. Middle East and Africa Cancer Tumor Profiling Revenue (Million USD) by Countries (2015-2020)

Table 130. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Table 131. Global Cancer Tumor Profiling Revenue (Million USD) by Type (2015-2020)

Table 132. Global Cancer Tumor Profiling Revenue Share by Type (2015-2020)

Table 133. Global Cancer Tumor Profiling Revenue Forecast by Type (2021-2025)

Table 134. Global Cancer Tumor Profiling Revenue by Application (2015-2020)

Table 135. Global Cancer Tumor Profiling Revenue Share by Application (2015-2020)

Table 136. Global Cancer Tumor Profiling Revenue Forecast by Application (2021-2025)

Table 137. Global Cancer Tumor Profiling Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Cancer Tumor Profiling Picture

Figure 2. Global Cancer Tumor Profiling Revenue Market Share by Type in 2019

Figure 3. Next-generation Sequencing (NGS) Picture

Figure 4. Polymerase Chain Reaction (PCR) Picture

Figure 5. Immunohistochemistry (IHC) Picture

Figure 6. In Situ Hybridization (ISH) Picture

Figure 7. Microarray Picture

Figure 8. Others Picture

Figure 9. Cancer Tumor Profiling Revenue Market Share by Application in 2019

Figure 10. Personalized Medicine Picture

Figure 11. Diagnostics Picture

Figure 12. Biomarker Discovery Picture

Figure 13. Prognostics Picture

Figure 14. Research Applications Picture

Figure 15. Global Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2015-2025)

Figure 16. North America Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Europe Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. Asia-Pacific Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)

Figure 19. South America Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)

Figure 20. Middle East and Africa Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)

Figure 21. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (2015-2025)

Figure 22. Global Cancer Tumor Profiling Revenue Share by Players in 2019

Figure 23. Global Top 5 Players Cancer Tumor Profiling Revenue Market Share in 2019

Figure 24. Global Top 10 Players Cancer Tumor Profiling Revenue Market Share in 2019

Figure 25. Key Players Market Share Trend

Figure 26. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 27. Global Cancer Tumor Profiling Revenue Market Share by Regions (2015-2020)

Figure 28. Global Cancer Tumor Profiling Revenue Market Share by Regions in 2018

Figure 29. North America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 30. Europe Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 31. Asia-Pacific Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 32. South America Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 33. Middle East and Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 34. North America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Figure 35. North America Cancer Tumor Profiling Revenue Market Share by Countries in 2019

Figure 36. USA Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 37. Canada Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 38. Mexico Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 39. Europe Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Figure 40. Europe Cancer Tumor Profiling Revenue Market Share by Countries in 2019

Figure 41. Germany Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 42. UK Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 43. France Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 44. Russia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 45. Italy Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 46. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Figure 47. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Countries in 2019

Figure 48. China Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 49. Japan Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 50. Korea Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 51. India Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 52. Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 53. South America Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Figure 54. South America Cancer Tumor Profiling Revenue Market Share by Countries in 2019

Figure 55. Brazil Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 56. Argentina Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 57. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries (2015-2020)

Figure 58. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Countries in 2019

Figure 59. Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 60. UAE Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 61. Egypt Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 62. South Africa Cancer Tumor Profiling Revenue and Growth Rate (2015-2020)

Figure 63. Global Cancer Tumor Profiling Revenue Share by Type (2015-2020)

Figure 64. Global Cancer Tumor Profiling Revenue Share by Type in 2019

Figure 65. Global Cancer Tumor Profiling Market Share Forecast by Type (2021-2025)

Figure 66. Global Next-generation Sequencing (NGS) Revenue Growth Rate (2015-2020)

Figure 67. Global Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2020)

Figure 68. Global Immunohistochemistry (IHC) Revenue Growth Rate (2015-2020)

Figure 69. Global In Situ Hybridization (ISH) Revenue Growth Rate (2015-2020)

Figure 70. Global Microarray Revenue Growth Rate (2015-2020)

Figure 71. Global Others Revenue Growth Rate (2015-2020)

Figure 72. Global Cancer Tumor Profiling Revenue Share by Application (2015-2020)

Figure 73. Global Cancer Tumor Profiling Revenue Share by Application in 2019

Figure 74. Global Cancer Tumor Profiling Market Share Forecast by Application (2021-2025)

Figure 75. Global Personalized Medicine Revenue Growth Rate (2015-2020)

Figure 76. Global Diagnostics Revenue Growth Rate (2015-2020)

Figure 77. Global Biomarker Discovery Revenue Growth Rate (2015-2020)

Figure 78. Global Prognostics Revenue Growth Rate (2015-2020)

Figure 79. Global Research Applications Revenue Growth Rate (2015-2020)

Figure 80. Global Cancer Tumor Profiling Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 81. Global Cancer Tumor Profiling Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 82. Global Cancer Tumor Profiling Revenue Market Share Forecast by Regions (2021-2025)

Figure 83. North America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

Figure 84. Europe Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

Figure 85. Asia-Pacific Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

Figure 86. South America Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

Figure 87. Middle East and Africa Cancer Tumor Profiling Revenue Market Forecast (2021-2025)

Figure 88. Sales Channel: Direct Channel vs Indirect Channel

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!